Abstract
Bone marrow transplantation has been successfully employed in the treatment of Diamond–Blackfan anemia (DBA). Transplantation with bone marrow stem cells involves, however, considerable treatment-related toxicity, partially in the form of GVHD. Through the use of cord blood stem cells it may be possible to reduce the risk for both acute and chronic GVHD, although possibly in the face of an increased risk for non-engraftment. We report the successful treatment of a boy with DBA by cord blood stem transplantation from an HLA-identical sibling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vettenranta, K., Saarinen, U. Cord blood stem cell transplantation for Diamond–Blackfan anemia. Bone Marrow Transplant 19, 507–508 (1997). https://doi.org/10.1038/sj.bmt.1700675
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700675
Keywords
This article is cited by
-
Diamond-Blackfan Anemia in Japan: Clinical Outcomes of Prednisolone Therapy and Hematopoietic Stem Cell Transplantation
International Journal of Hematology (2004)
-
Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry
Bone Marrow Transplantation (2001)
-
Epstein–Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond–Blackfan anemia
Bone Marrow Transplantation (2000)